HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Palliative embolization of kidney tumors using iodol-marked Ethibloc].

Abstract
In 59 patients having non-operable malignant renal tumours, palliative trans-catheter embolization was performed. In 42 of them follow-up observations were realized over 18 months. The average survival rate was then 43% of cases. Local tumour growth was documented in 9 patients (23%) due to recanalization of the embolized arteries (13%) and to non-occluded collateral vessels (10%). The choice of suitable embolizing materials mainly influences the therapeutic result: Oily contrast labeled amino-acid Ethibloc is considered to be the material of choice for safe application and reliable vascular distribution causing persisting occlusion of the renal arteries.
AuthorsJ Weber, J Kaufmann, K Kult
JournalRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin (Rofo) Vol. 141 Issue 4 Pg. 384-9 (Oct 1984) ISSN: 1438-9029 [Print] Germany
Vernacular TitlePalliative Nierentumorembolisation mittels Jodöl-markiertem Ethibloc.
PMID6208580 (Publication Type: Journal Article)
Chemical References
  • Drug Combinations
  • Fatty Acids
  • Propylene Glycols
  • Proteins
  • Diatrizoate
  • Iodized Oil
  • Zein
  • alcoholic prolamine solution
Topics
  • Aged
  • Diatrizoate
  • Drug Combinations
  • Embolization, Therapeutic
  • Fatty Acids
  • Female
  • Humans
  • Iodized Oil
  • Kidney Neoplasms (diagnostic imaging, therapy)
  • Male
  • Middle Aged
  • Palliative Care
  • Propylene Glycols
  • Proteins (therapeutic use)
  • Tomography, X-Ray Computed
  • Zein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: